Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
RecruitingOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
June 16, 2025
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Conditions
Atopic Dermatitis
Trial Locations (1)
F-69495
RECRUITING
Allergologie et Immunologie Clinique, CHU Lyon Sud, Pierre-Bénite
All Listed Sponsors
lead
Pierre Fabre Dermo Cosmetique
INDUSTRY
NCT06983561 - Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients | Biotech Hunter | Biotech Hunter